View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsPuriflOH 배당 및 자사주 매입배당 기준 점검 0/6PuriflOH 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Oct 13PuriflOH Limited, Annual General Meeting, Nov 30, 2022PuriflOH Limited, Annual General Meeting, Nov 30, 2022.공시 • Aug 31PuriflOH Limited Announces Positive Test Results on its New Generation of Neutralizer Free Air PurifiersThis technical update provides perspective and explanation to the results of independent performance testing conducted on behalf of PuriflOH Limited on its new generation of neutralizer free Air Purifiers. The work was conducted by Co-Labs of Brunswick, Victoria. Co-Labs is a Bio-safety Level 2 Laboratory that has recently installed a 75 cubic meter bio-aerosol testing chamber and is capable of testing various microbial organisms on surface or air using internationally accepted methods and equipment. Thus far, PuriflOH's approach on air purification has been to provide a single stage technology that can eliminate all air pollutants such as particles, odour, Volatile Organic Compounds (VOCs) and air-borne microbes. PuriflOH, initially through its research partner Somnio Global, and now operating through its own auspices, have continued to develop the Free Radical Generator (FRG)-based air purifiers. The new generation is now more powerful with a higher single-pass kill rate the factor of destruction of microbes between outlet and inlet of an air purifier. Existing products require 3-6 stages of filtration to achieve the same effectiveness. This is a significant and unique improvement over current air purification solutions. Since 2018, Somnio and PuriflOH have engaged with OEM companies in order for them to integrate versions of the Free Radical Generator (FRG) into existing designs to significantly enhance product performance. This OEM engagement has lead to useful market feedback and design changes. For example, the high concentration of radicals needed to significantly remove VOCs and other contaminants efficiently has necessitated neutralizer filters, which add to the overall size of the end product and cost as an air purifier. A result of the Covid-19 pandemic has been that market priorities have shifted to highlight microbial decontamination above all else. This has led to the company focusing its efforts on the Air Conditioner Remediation and Environmental Treatment (ACERT) device as its first commercial product and re- evaluating the design of its air purifiers. Recently, PuriflOH has been actively developing a low-power FRG addition to Air Purifiers, FRG+, that are simple to implement whilst providing significant benefits to the final product. The result of this approach is a new generation of Air Purifiers empowered by the FRG. This newly designed FRG module has the following performance features: An improvement of at least 150% in the speed and efficacy of air purification over current market leading devices. Safe operation in occupied spaces without the need for neutralizer filters. Only 10W of added power consumption. Reducing noise levels in existing air purifiers while improving efficacy. Independent testing and results: PuriflOH has concluded its first independent test on this new FRG+ version of an Air Purifier, conducted at Co-Labs Melbourne, which houses the world's largest and Australia's first Bio-aerosol testing chamber. The test was conducted with Staphylococcus epidermidis, a vegetative bacterium that is analogous to MRSA, a common hospital-acquired infection frequently used in testing disinfectant efficacies. PuriflOH's previous aerosol testing results were obtained from ARE Labs in the USA and performed in a chamber sized 15 cubic metres. The airflow rate of the "Bluemist" device provided for more than 12 air changes per hour in this previously tested chamber. In the test conducted at Co-labs, the chamber volume was 5 times larger (75 m3) and the flow rate allowed for only 5 air changes every hour. Smaller air changes typically increase the time taken to achieve total disinfection. This air exchange rate of 5 per hour is similar to how ventilation and air purification systems are configured in the real world. Despite the larger chamber size and the lower exchange rate, the new FRG+ device was able to achieve 99% reduction in airborne bacteria in approximately 30 mins, at least 1.5 times faster than a standard HEPA based air purifier acting under the same conditions. Moreover, ozone levels in the chamber were tested to remain well within acceptable values, allowing the device to be used in occupied spaces. Commercial impact of new design This new format of the FRG has been designed to incorporate a simple manufacturing and installation process that should increase chances of commercial success. The new design also creates new opportunities for PuriflOH and removes existing obstacles as: This design is highly cost effective and significantly upgrades the efficacy of air purifiers. The design is suitable for businesses, offering a highly effective solution with low operational expenses such as maintenance and power consumption. The FRG is now a retrofit solution to existing air purifiers. The design is easily adaptable to any existing residential or commercial air purifier, thereby making it a very easy OEM solution. PuriflOH will continue to seek internal and external validation of FRG+ Air Purifiers on a roster of challenge organisms including viruses and fungal/bacterial spores, while driving the development towards improved performance in occupied spaces without the need for neutralizer filters.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Mar 31Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be €0.64, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% over the last 3 years. Earnings per share has grown by 9.8%.Buying Opportunity • Mar 15Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 53%. The fair value is estimated to be AU$0.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% per annum over the last 3 years. Earnings per share has grown by 9.8% per annum over the last 3 years.Board Change • Nov 02Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Executive Departure • Apr 25Independent Non-Executive Director has left the companyOn the 22nd of April, Pravansu Mohanty's tenure as Independent Non-Executive Director ended after 1.4 years in the role. We don't have any record of a personal shareholding under Pravansu's name. A total of 2 executives have left over the last 12 months.Is New 90 Day High Low • Mar 06New 90-day low: €0.65The company is down 21% from its price of €0.82 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 3.0% over the same period.Is New 90 Day High Low • Feb 02New 90-day low: €0.66The company is down 33% from its price of €0.98 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is flat over the same period.Is New 90 Day High Low • Jan 06New 90-day low: €0.75The company is down 14% from its price of €0.88 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.공시 • Oct 29PuriflOH Ltd Announces Appointment of Jonathon (Jon) Evans as a DirectorPuriflOH Ltd. announced the appointment of Mr. Jonathon (Jon) Evans as a Director of PuriflOH, effective as of 29 October 2020. His career spans over 30 years, including as CEO of an Australian Hospital Group; Director of a State-based Infectious Disease Reference Laboratory; CEO of Tellimed Health Services; Director of Health Strategy and Innovation for Victorian Government; Managing Partner of Fitzroy Health Asia Pacific- an Australian/US Health Commercialisation company and most recently as Managing Director, APAC Health Solutions Group. Mr. Evans is also chairman of CEMTAS Australia.Is New 90 Day High Low • Sep 28New 90-day low: €0.68The company is down 55% from its price of €1.49 on 30 June 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.공시 • Sep 18PuriflOH Limited Announces Management ChangesPurifloh Limited ("PuriflOH" or "Company") announced the resignation of the Chairman Mr. Bill Parfet, with immediate effect. Mr. Parfet resigns as both Chairman and Director of the Board. The Company's major shareholder, Dilato Holdings Pty Ltd, is controlled by Purifloh director, Mr. Carl Le Souef, who will take up the role of Chairman on an interim basis.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 WXV 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: WXV 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장PuriflOH 배당 수익률 vs 시장WXV의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (WXV)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.8%업계 평균 (Water Utilities)4.5%분석가 예측 (WXV) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 WXV 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 WXV 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 WXV 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: WXV 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/05/14 01:22종가2023/02/14 00:00수익2022/12/31연간 수익2022/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스PuriflOH Limited는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Oct 13PuriflOH Limited, Annual General Meeting, Nov 30, 2022PuriflOH Limited, Annual General Meeting, Nov 30, 2022.
공시 • Aug 31PuriflOH Limited Announces Positive Test Results on its New Generation of Neutralizer Free Air PurifiersThis technical update provides perspective and explanation to the results of independent performance testing conducted on behalf of PuriflOH Limited on its new generation of neutralizer free Air Purifiers. The work was conducted by Co-Labs of Brunswick, Victoria. Co-Labs is a Bio-safety Level 2 Laboratory that has recently installed a 75 cubic meter bio-aerosol testing chamber and is capable of testing various microbial organisms on surface or air using internationally accepted methods and equipment. Thus far, PuriflOH's approach on air purification has been to provide a single stage technology that can eliminate all air pollutants such as particles, odour, Volatile Organic Compounds (VOCs) and air-borne microbes. PuriflOH, initially through its research partner Somnio Global, and now operating through its own auspices, have continued to develop the Free Radical Generator (FRG)-based air purifiers. The new generation is now more powerful with a higher single-pass kill rate the factor of destruction of microbes between outlet and inlet of an air purifier. Existing products require 3-6 stages of filtration to achieve the same effectiveness. This is a significant and unique improvement over current air purification solutions. Since 2018, Somnio and PuriflOH have engaged with OEM companies in order for them to integrate versions of the Free Radical Generator (FRG) into existing designs to significantly enhance product performance. This OEM engagement has lead to useful market feedback and design changes. For example, the high concentration of radicals needed to significantly remove VOCs and other contaminants efficiently has necessitated neutralizer filters, which add to the overall size of the end product and cost as an air purifier. A result of the Covid-19 pandemic has been that market priorities have shifted to highlight microbial decontamination above all else. This has led to the company focusing its efforts on the Air Conditioner Remediation and Environmental Treatment (ACERT) device as its first commercial product and re- evaluating the design of its air purifiers. Recently, PuriflOH has been actively developing a low-power FRG addition to Air Purifiers, FRG+, that are simple to implement whilst providing significant benefits to the final product. The result of this approach is a new generation of Air Purifiers empowered by the FRG. This newly designed FRG module has the following performance features: An improvement of at least 150% in the speed and efficacy of air purification over current market leading devices. Safe operation in occupied spaces without the need for neutralizer filters. Only 10W of added power consumption. Reducing noise levels in existing air purifiers while improving efficacy. Independent testing and results: PuriflOH has concluded its first independent test on this new FRG+ version of an Air Purifier, conducted at Co-Labs Melbourne, which houses the world's largest and Australia's first Bio-aerosol testing chamber. The test was conducted with Staphylococcus epidermidis, a vegetative bacterium that is analogous to MRSA, a common hospital-acquired infection frequently used in testing disinfectant efficacies. PuriflOH's previous aerosol testing results were obtained from ARE Labs in the USA and performed in a chamber sized 15 cubic metres. The airflow rate of the "Bluemist" device provided for more than 12 air changes per hour in this previously tested chamber. In the test conducted at Co-labs, the chamber volume was 5 times larger (75 m3) and the flow rate allowed for only 5 air changes every hour. Smaller air changes typically increase the time taken to achieve total disinfection. This air exchange rate of 5 per hour is similar to how ventilation and air purification systems are configured in the real world. Despite the larger chamber size and the lower exchange rate, the new FRG+ device was able to achieve 99% reduction in airborne bacteria in approximately 30 mins, at least 1.5 times faster than a standard HEPA based air purifier acting under the same conditions. Moreover, ozone levels in the chamber were tested to remain well within acceptable values, allowing the device to be used in occupied spaces. Commercial impact of new design This new format of the FRG has been designed to incorporate a simple manufacturing and installation process that should increase chances of commercial success. The new design also creates new opportunities for PuriflOH and removes existing obstacles as: This design is highly cost effective and significantly upgrades the efficacy of air purifiers. The design is suitable for businesses, offering a highly effective solution with low operational expenses such as maintenance and power consumption. The FRG is now a retrofit solution to existing air purifiers. The design is easily adaptable to any existing residential or commercial air purifier, thereby making it a very easy OEM solution. PuriflOH will continue to seek internal and external validation of FRG+ Air Purifiers on a roster of challenge organisms including viruses and fungal/bacterial spores, while driving the development towards improved performance in occupied spaces without the need for neutralizer filters.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Mar 31Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be €0.64, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% over the last 3 years. Earnings per share has grown by 9.8%.
Buying Opportunity • Mar 15Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 53%. The fair value is estimated to be AU$0.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% per annum over the last 3 years. Earnings per share has grown by 9.8% per annum over the last 3 years.
Board Change • Nov 02Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Executive Departure • Apr 25Independent Non-Executive Director has left the companyOn the 22nd of April, Pravansu Mohanty's tenure as Independent Non-Executive Director ended after 1.4 years in the role. We don't have any record of a personal shareholding under Pravansu's name. A total of 2 executives have left over the last 12 months.
Is New 90 Day High Low • Mar 06New 90-day low: €0.65The company is down 21% from its price of €0.82 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 3.0% over the same period.
Is New 90 Day High Low • Feb 02New 90-day low: €0.66The company is down 33% from its price of €0.98 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is flat over the same period.
Is New 90 Day High Low • Jan 06New 90-day low: €0.75The company is down 14% from its price of €0.88 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.
공시 • Oct 29PuriflOH Ltd Announces Appointment of Jonathon (Jon) Evans as a DirectorPuriflOH Ltd. announced the appointment of Mr. Jonathon (Jon) Evans as a Director of PuriflOH, effective as of 29 October 2020. His career spans over 30 years, including as CEO of an Australian Hospital Group; Director of a State-based Infectious Disease Reference Laboratory; CEO of Tellimed Health Services; Director of Health Strategy and Innovation for Victorian Government; Managing Partner of Fitzroy Health Asia Pacific- an Australian/US Health Commercialisation company and most recently as Managing Director, APAC Health Solutions Group. Mr. Evans is also chairman of CEMTAS Australia.
Is New 90 Day High Low • Sep 28New 90-day low: €0.68The company is down 55% from its price of €1.49 on 30 June 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.
공시 • Sep 18PuriflOH Limited Announces Management ChangesPurifloh Limited ("PuriflOH" or "Company") announced the resignation of the Chairman Mr. Bill Parfet, with immediate effect. Mr. Parfet resigns as both Chairman and Director of the Board. The Company's major shareholder, Dilato Holdings Pty Ltd, is controlled by Purifloh director, Mr. Carl Le Souef, who will take up the role of Chairman on an interim basis.